IBNSINA PHARMA financial statements, including revenue, expenses, profit, and loss

The total revenue of ISPH for the last quarter is 10.14 B EGP, and it's 11.37% higher compared to the previous quarter. The net income of Q4 23 is 32.09 M EGP.